Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tranylcypromine (2-PCPA) hydrochloride (SKF-385 HCl) 是一种单胺氧化酶抑制剂,对治疗重度抑郁症、心境恶劣障碍和非典型抑郁症有效。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
50 mg | ¥ 258 | 现货 | ||
100 mg | ¥ 413 | 现货 | ||
200 mg | ¥ 543 | 现货 | ||
500 mg | ¥ 849 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 150 | 现货 |
产品描述 | Tranylcypromine (2-PCPA) hydrochloride (SKF-385 HCl), a Monoamine Oxidase inhibitor, is effective in the treatment of major depression, dysthymic disorder, and atypical depression. |
靶点活性 | LSD1:22.3 μM, MAO-A:11.5 μM, MAO-B:7 μM |
体外活性 | 与空白对照组相比,Tranylcypromine(5 mg/kg和10 mg/kg)可大而缓的增加雄性大鼠的肌肉活动,但2 mg/kg的Tranylcypromine没有效果. Tranylcypromine(10 mg/kg)使雄性大鼠饲养行为数量显著增加. |
体内活性 | 在小牛主动脉内皮细胞中,Tranylcypromine(500 μg/mL)可强烈抑制缓激肽诱导的花生四烯酸释放。 Tranylcypromine还能抑制HLMs中的CYP2A6(IC50:0.42 μM)和CYP2E1(IC50:3 μM)活性。在HLMs中,Tranylcypromine引起II型和环丙基苯I型的差异谱。HLMs中CYP2A6介导的尼古丁代谢可被R-(+)-Tranylcypromine(Ki:0.05 μM),(±)-Tranylcypromine(Ki:0.08 μM)以及S-(-)-Tranylcypromine(Ki:2.0 μM)完全抑制。 |
激酶实验 | PDE activity is determined with some modifications. The assay mixture contain 50 mM Tris (pH 7.4), 5 mM MgCl2, 0.5 μM cAMP or cGMP, and [3H]cAMP or [3H]cGMP (about 30,000 cpm/assay), the indicated concentration of the inhibitor and an aliquot of the enzyme solution at a final assay volume of 200 μL. Stock solutions of the compounds are diluted 1:100 (v/v) in the Tris buffer mentioned above; appropriate dilutions are prepared in 1% (v/v) DMSO/Tris buffer, which are diluted 1:2 (v/v) in the assays to obtain the desired final concentrations of the inhibitors at a DMSO concentration of 0.5% (v/v). DMSO itself affected none of the PDE activities. After preincubation for 5 min at 37°C, the reaction is started by the addition of substrate (cAMP or cGMP) and the assays are incubated for further 15 min at 37°C. Then 50 μL of 0.2 N HCl is added to stop the reaction and the assays are left on ice for about 10 min. Following incubation with 25 μg of 5′-nucleotidase (Crotalus atrox snake venom) for 10 min at 37°C, the assays are loaded on QAE Sephadex A-25 (1 mL of bed volume in Poly-Prep chromatography columns). The columns are eluted with 2 mL of 30 mM ammonium formate (pH 6.0) and the eluate is counted for radioactivity. Results are corrected for blank values (measured in the presence of denatured protein) that are below 5% of total radioactivity. The amount of cyclic nucleotides hydrolyzed did not exceed 30% of the original substrate concentration[3]. |
别名 | 反苯环丙胺盐酸盐, Tranylcypromine (2-PCPA) HCl, SKF-385 HCl |
分子量 | 169.66 |
分子式 | C9H11N·HCl |
CAS No. | 1986-47-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 17 mg/mL (100 mM)
DMSO: 17 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 5.8941 mL | 29.4707 mL | 58.9414 mL | 147.3535 mL |
5 mM | 1.1788 mL | 5.8941 mL | 11.7883 mL | 29.4707 mL | |
10 mM | 0.5894 mL | 2.9471 mL | 5.8941 mL | 14.7354 mL | |
20 mM | 0.2947 mL | 1.4735 mL | 2.9471 mL | 7.3677 mL | |
50 mM | 0.1179 mL | 0.5894 mL | 1.1788 mL | 2.9471 mL | |
100 mM | 0.0589 mL | 0.2947 mL | 0.5894 mL | 1.4735 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Tranylcypromine (2-PCPA) hydrochloride 1986-47-6 Chromatin/Epigenetic Metabolism Neuroscience Histone Demethylase MAO 反苯环丙胺盐酸盐 Tranylcypromine (2-PCPA) Hydrochloride Tranylcypromine (2-PCPA) HCl Tranylcypromine (2PCPA) hydrochloride SKF-385 HCl Tranylcypromine (2 PCPA) hydrochloride Inhibitor inhibitor inhibit